Ad
related to: moderna share price prediction next 30 days charlotte nc free peoplehugealerts.com has been visited by 10K+ users in the past month
Search results
Results From The WOW.Com Content Network
There was good news to share, but the market focused on a declining sales forecast and hammered the stock lower. Last November, Moderna said it expected 2024 revenue to land in a range between $3 ...
The forecast also accounted for Moderna's prediction that each of the 10 new products it expects to be approved by 2027 will start to generate meaningful revenue the year after they are approved ...
By early 2028, Moderna will be firmly within its next phase of life, potentially operating more like a traditional pharmaceutical business than like an up-and-coming biotech with a lot to prove ...
For premium support please call: 800-290-4726 more ways to reach us
At the healthcare conference, Moderna lowered expected 2025 revenue to the range of $1.5 billion to $2.5 billion -- down from a September forecast of $2.5 billion to $3.5 billion. And Moderna said ...
Moderna's (MRNA) shares are rising presumably in anticipation of rising demand for its COVID-19 vaccine amid authorization for younger population and the fear of another global infection wave.
Moderna (MRNA) appears to be in oversold territory after a prolonged share-price drawdown. MRNA stock could be due for a rebound in light of encouraging news for Moderna. Investors should consider ...
For premium support please call: 800-290-4726 more ways to reach us